Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Terns Pharmaceuticals Inc (NASDAQ: TERN) closed at $3.63 in the last session, up 3.42% from day before closing price of $3.51. In other words, the price has increased by $3.42 from its previous closing price. On the day, 0.99 million shares were traded.
Ratios:
We take a closer look at TERN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 32.99 and its Current Ratio is at 32.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 31, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $82.
On June 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $16.Mizuho initiated its Buy rating on June 22, 2023, with a $16 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 30 ’24 when Jung Melita Sun bought 2,250 shares for $5.11 per share. The transaction valued at 11,498 led to the insider holds 2,250 shares of the business.
Burroughs Amy L. bought 510 shares of TERN for $2,606 on Nov 30 ’24. The Chief Executive Officer now owns 19,609 shares after completing the transaction at $5.11 per share. On Jan 02 ’25, another insider, Kuriakose Emil, who serves as the Chief Medical Officer of the company, sold 4,481 shares for $5.71 each. As a result, the insider received 25,607 and left with 54,269 shares of the company.
Stock Price History:
Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $3.27. The 50-Day Moving Average of the stock is -21.88%, while the 200-Day Moving Average is calculated to be -46.23%.
Shares Statistics:
A total of 84.92M shares are outstanding, with a floating share count of 63.53M. Insiders hold about 25.20% of the company’s shares, while institutions hold 80.80% stake in the company.
